October 22, 2021
Stem Cells

Stem Cells Market Size, Growth Insight, Trends and Forecasts to 2027

The global stem cells market value is expected to reach US$ 17.79 Billion by the end of 2027, decelerating at a CAGR of 8.61% from 2020 to 2027. The report contains 150+ pages with detailed analysis.

The study provides the overall revenue of the global stem cells market from 2016 to 2027, considering 2020 as the base year and 2027 as the forecast year.

The global stem cells market research report gives a brief summary of definitions, size analysis, and place of production, sales, applications, types, and major players/key vendors of the stem cells industry. The report presents fresh perspectives on opportunities and challenges in a significantly transformed post-COVID-19 marketplace. This research study also integrates Industry Chain analysis and Porter’s Five Forces Analysis. Further, this report offers a competitive scenario that comprises collaborations, market concentration rate and expansions, mergers & acquisitions undertaken by companies.

Growth factors

Since past few years, stem cells market is growing with the increasing investment in stem cell-based research by biopharmaceutical and pharmaceutical firm along with the success of regenerative medicines. Stem cells market is growth is backed by escalating number of clinical trials across the world. Some of the major factors driving the growth of the stem cells market include advancement in stem cell manufacturing technology as well as increasing harvest awareness regarding therapeutic potency. High occurrences of infections have steered the development of vaccines using various human diploid and non-tumorigenic cell lines.

Growing demands as well as awareness along with ongoing research and development of vaccines against different diseases are certain growth influencers of the stem cells market. Additionally, prevalence of chronic diseases will also fuel the market growth. Presence of advanced stem cells banking and availability of stem cells donor will significantly boost the market demand during upcoming years. Rigorous support of government via different initiatives aids stem cells banking to obtain significance. Increasing number of stem cells banks in emerging economies is further encouraging market penetration. Also, growing awareness about stem cell harvest which holds high potential in therapeutic and diagnosis field offers lucrative prospects to the market during impending years.

Intensifying prevalence of cancer worldwide is offering substantial boost to the growth of cancer stem cells market. As per the data published by World Health Organization, the global cancer implication is projected to have risen to around 18 million latest cases and around 9.2 million deaths in year 2018. Additionally, according to Cancer Research UK, the population enduring the cancer is anticipated to grow in near future.

Report Highlights

  • Increasing prevalence of chronic diseases significantly drive the stem cells market across the globe.
  • Rising Stem cell-based research and development, government initiatives and investment by pharmaceutical firms in stem cells fuel the growth of the stem cells market.
  • Growing donors of stem cells and advanced stem cell banking will further propel the market growth.
  • Huge success of regenerative medicines and increasing adoption of stem cell therapies are the factors projected to positively impact the stem cells market over the forecast period.
  • Budding regulatory frameworks for stem cell therapeutics in Europe and the U.S.is flourishing the stem cell technology acceptance
  • The cell acquisition technology dominated the stem cells market in 2019
  • The Allogeneic therapy acquired largest market share among different therapy segments in 2019

Regional Snapshot

North America held the largest share in the market and is anticipated to continue its dominance over the forecast period due to existence of organized and developed healthcare systems which uplift research and development in the U.S. and Canada. Asia Pacific is likely to grow with the highest Compound Annual Growth Rate (CAGR) owing to wide usage of stem cells in regenerative medicines particularly in the sector of dermatology. Oncology applications are expected to grow at highest CAGR owing to large number of pipeline products available for the cure of cancer and tumors. Growing number of regenerative medicines centers are in turn expected to drive the stem cell in near future.

Related Reports

  • Genomics Market – The global market size was valued at USD 20.06 billion in 2020 and is expected to hit over USD 72.13 billion by 2030, expanding at a compound annual growth rate (CAGR) of 13.65% during forecast period 2021 to 2030.
  • Generic Drugs Market – The global market size was valued at USD 387.92 billion in 2020 and is predicted to hit around USD 675.29 billion by the end of 2030, representing impressive CAGR of 5.7% during the forecast period 2021 to 2030.
  • Cancer Diagnostics Market – The global market size was valued at USD 115.60 billion in 2020 and expected to reach around USD 261.34 billion by the end of 2030, exhibiting a Compound Annual Growth Rate (CAGR) of 8.4% during forecast period 2021 to 2030.

Top Players Contending in the Market:

The key companies are aiming towards advanced innovations and are predictable to dominate the target market. Foremost players inspiring in the global stem cells market are as follows:

  • STEMCELL Technologies, Inc.
  • Osiris Therapeutics, Inc.
  • Cynata Therapeutics
  • Human Longevity, Inc.
  • Advanced Cell Technology, Inc.
  • BIOTIME, Inc.
  • Mesoblast Limited
  • Promethera Biosciences S.A. / N.V.
  • Merck Group
  • Takara Bio Group

Market Segmentation

 

Regional Segment

Segments Covered in the Report

This research study comprises complete assessment of the market by means of far-reaching qualitative and quantitative perceptions, and predictions regarding the market. This report delivers classification of marketplace into impending and niche sectors. Further, this research study calculates market size and its development drift at global, regional, and country from 2016 to 2027. This report contains market breakdown and its revenue estimation by classifying it on the basis of product, application, technology, therapy and region as follows:

By Product

  • Adult Stem Cells
    • Neuronal Stem Cells
    • Mesenchymal Stem Cells
    • Dental Stem Cells
    • Umbilical Cord Stem Cells
    • Adipose-derived Stem Cells
    • HematopoieticStem Cells
    • Dedifferentiated fat (DFAT) Cells
    • Other ASC’s
  • Very Small Embryonic Like Stem Cells
  • Human Embryonic Stem Cells
  • Induced Pluripotent Stem Cells

By Application

  • Regenerative Medicine
    • Neurology
    • Oncology
    • Hematology
    • Injuries
    • Orthopedics
    • Incontinence
    • Diabetes
    • Liver Disorder
    • Others
  • Drug Discovery and development

By Technology

  • Cell Acquisition
    • Apheresis
    • Bone Marrow Harvest
    • Umbilical Blood Cord
  • Cryopreservation
  • Cell production
    • Therapeutic Cloning
    • Cell Culture
    • In-Vitro fertilization
    • Isolation
  • Expansion and Sub-Culture

By Therapy

  • Allogenic Stem Cell Therapy
  • Autologous Stem Cell Therapy

ation

  • North America (U.S. and Canada)
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
  • Latin America (Brazil and Rest of Latin America)
  • Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Some of the key highlights covered in the report include:

Market Demand-Supply Analysis – The report covers detailed insights into demand and supply forces prevailing in the global stem cells market. It examines trends and factors influencing demand for stem cells globally and gauges the impact of the same on the production.

Pricing Analysis – The report presents an exclusive pricing analysis. It compares pricing strategies adopted by the leading market players and identifies the most remunerative strategies.

Market Segmentation – The report segments the global market in terms of diverse criteria. It identifies the leading segment within each category and identifies growth drivers and restraints affecting growth across each segment.

Regional Analysis – The report segments the market in terms of North America, Europe, Latin America, Asia Pacific, and Rest of the World in terms of region. It has chapters exclusively dedicated to analyzing growth trends across each region. It identifies growth drivers as well challenges affecting demand for stem cells across the world.

Competitive Analysis – Some of the leading market players are profiled in the report on stem cells. The report offers an estimation of share individually help by the market players and determines the impact of some of their popular strategies.

COVID-19 Impact Analysis – This chapter is exclusively dedicated to gauging how the market has evolved or will develop in the post-pandemic era.

Growth Recommendations – In the end, the report presents valuable recommendations to ready businesses for unforeseen challenges in the near future.

Why should you invest in this report?

If you are aiming to enter the global stem cells market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for stem cells are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2020-2027 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Stem Cell Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on Stem Cell Market

5.1. Covid-19: Stem Cell Industry Impact
5.2. Stem Cell Business Impact Assessment: Covid-19
5.2.1. Supply Chain Challenges/Disruption
5.2.2. Market Trends and Stem Cell Opportunities in the COVID-19 Landscape
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Stem Cell Manufacturers to deal with Covid-19 Pandemic Scenario

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition

Chapter 7. Global Stem Cell Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Stem Cell Market Revenue by Manufacturer (2015-2020)
7.1.1.2. Stem Cell Market Revenue Market Share by Manufacturer (2015-2020)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Capacity Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers

Chapter 8. Global Stem Cell Market, By Product Type

8.1. Stem Cell Market, by Product Type, 2016-2027
8.1.1. Adult Stem Cells
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Very Small Embryonic Like Stem Cells
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Human Embryonic Stem Cells
8.1.3.1. Market Revenue and Forecast (2016-2027)
8.1.4. Induced Pluripotent Stem Cells
8.1.4.1. Market Revenue and Forecast (2016-2027)

Chapter 9. Global Stem Cell Market, By Application

9.1. Stem Cell Market, by Application, 2016-2027
9.1.1. Regenerative Medicine
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Drug Discovery and development
9.1.2.1. Market Revenue and Forecast (2016-2027)

Chapter 10. Global Stem Cell Market, By Technology

10.1. Stem Cell Market, By Technology, 2016-2027
10.1.1. Cell Acquisition
10.1.1.1. Market Revenue and Forecast (2016-2027)
10.1.2. Cryopreservation
10.1.2.1. Market Revenue and Forecast (2016-2027)
10.1.3. Cell production
10.1.3.1. Market Revenue and Forecast (2016-2027)
10.1.4. Expansion and Sub-Culture
10.1.4.1. Market Revenue and Forecast (2016-2027)

Chapter 11. Global Stem Cell Market, Regional Estimates and Trend Forecast

11.1. North America
11.1.1. Market Revenue Forecast by Product (2016-2027)
11.1.2. Market Revenue Forecast by Application (2016-2027)
11.1.3. Market Revenue Forecast By Technology (2016-2027)
11.1.4. U.S
11.1.4.1. Market Revenue Forecast (2016-2027)
11.1.4.2. Market Revenue Forecast (2016-2027)
11.1.5. Canada
11.1.5.1. Market Revenue Forecast (2016-2027)
11.1.5.2. Market Revenue Forecast (2016-2027)
11.2. Europe
11.2.1. Market Revenue Forecast by Product (2016-2027)
11.2.2. Market Revenue Forecast by Application (2016-2027)
11.2.3. Market Revenue Forecast By Technology (2016-2027)
11.2.4. UK
11.2.4.1. Market Revenue Forecast (2016-2027)
11.2.4.2. Market Revenue Forecast (2016-2027)
11.2.5. Germany
11.2.5.1. Market Revenue Forecast (2016-2027)
11.2.5.2. Market Revenue Forecast (2016-2027)
11.2.6. France
11.2.6.1. Market Revenue Forecast (2016-2027)
11.2.6.2. Market Revenue Forecast (2016-2027)
11.2.7. Rest of EU
11.2.7.1. Market Revenue Forecast (2016-2027)
11.2.7.2. Market Revenue Forecast (2016-2027)
11.3. Asia Pacific (APAC)
11.3.1. Market Revenue Forecast by Product (2016-2027)
11.3.2. Market Revenue Forecast by Application (2016-2027)
11.3.3. Market Revenue Forecast By Technology (2016-2027)
11.3.4. China
11.3.4.1. Market Revenue Forecast (2016-2027)
11.3.4.2. Market Revenue Forecast (2016-2027)
11.3.5. India
11.3.5.1. Market Revenue Forecast (2016-2027)
11.3.5.2. Market Revenue Forecast (2016-2027)
11.3.6. Japan
11.3.6.1. Market Revenue Forecast (2016-2027)
11.3.6.2. Market Revenue Forecast (2016-2027)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue Forecast (2016-2027)
11.3.7.2. Market Revenue Forecast (2016-2027)
11.4. LATAM
11.4.1. Market Revenue Forecast by Product (2016-2027)
11.4.2. Market Revenue Forecast by Application (2016-2027)
11.4.3. Market Revenue Forecast by Technology (2016-2027)
11.4.4. Brazil
11.4.4.1. Market Revenue Forecast (2016-2027)
11.4.4.2. Market Revenue Forecast (2016-2027)
11.4.5. Rest of LATAM
11.4.5.1. Market Revenue Forecast (2016-2027)
11.4.5.2. Market Revenue Forecast (2016-2027)
11.5. Middle East and Africa (MEA)
11.5.1. Market Revenue Forecast by Product (2016-2027)
11.5.2. Market Revenue Forecast by Application (2016-2027)
11.5.3. Market Revenue Forecast by Technology (2016-2027)
11.5.4. GCC
11.5.4.1. Market Revenue Forecast (2016-2027)
11.5.4.2. Market Revenue Forecast (2016-2027)
11.5.5. North Africa
11.5.5.1. Market Revenue Forecast (2016-2027)
11.5.5.2. Market Revenue Forecast (2016-2027)
11.5.6. South Africa
11.5.6.1. Market Revenue Forecast (2016-2027)
11.5.6.2. Market Revenue Forecast (2016-2027)
11.5.7. Rest of MEA
11.5.7.1. Market Revenue Forecast (2016-2027)
11.5.7.2. Market Revenue Forecast (2016-2027)

Chapter 12. Company Profiles

12.1. Company 1
12.1.1. Company Overview, Business Information, Manufacturing Area
12.1.2. Product Portfolio Analysis
12.1.2.1. Product Details, Specification, Application
12.1.3. Revenue and Gross Margin (2015-2020)
12.1.4. Recent Developments and Strategies
12.2. STEMCELL Technologies, Inc.
12.2.1. Company Overview, Business Information, Manufacturing Area
12.2.2. Product Portfolio Analysis
12.2.2.1. Product Details, Specification, Application
12.2.3. Revenue and Gross Margin (2015-2020)
12.2.4. Recent Developments and Strategies
12.3. Osiris Therapeutics, Inc.
12.3.1. Company Overview, Business Information, Manufacturing Area
12.3.2. Product Portfolio Analysis
12.3.2.1. Product Details, Specification, Application
12.3.3. Revenue and Gross Margin (2015-2020)
12.3.4. Recent Developments and Strategies
12.4. Cynata Therapeutics
12.4.1. Company Overview, Business Information, Manufacturing Area
12.4.2. Product Portfolio Analysis
12.4.2.1. Product Details, Specification, Application
12.4.3. Revenue and Gross Margin (2015-2020)
12.4.4. Recent Developments and Strategies
12.5. Human Longevity, Inc.
12.5.1. Company Overview, Business Information, Manufacturing Area
12.5.2. Product Portfolio Analysis
12.5.2.1. Product Details, Specification, Application
12.5.3. Revenue and Gross Margin (2015-2020)
12.5.4. Recent Developments and Strategies
12.6. Advanced Cell Technology, Inc.
12.6.1. Company Overview, Business Information, Manufacturing Area
12.6.2. Product Portfolio Analysis
12.6.2.1. Product Details, Specification, Application
12.6.3. Revenue and Gross Margin (2015-2020)
12.6.4. Recent Developments and Strategies
12.7. BIOTIME, Inc.
12.7.1. Company Overview, Business Information, Manufacturing Area
12.7.2. Product Portfolio Analysis
12.7.2.1. Product Details, Specification, Application
12.7.3. Revenue and Gross Margin (2015-2020)
12.7.4. Recent Developments and Strategies
12.8. Mesoblast Limited
12.8.1. Company Overview, Business Information, Manufacturing Area
12.8.2. Product Portfolio Analysis
12.8.2.1. Product Details, Specification, Application
12.8.3. Revenue and Gross Margin (2015-2020)
12.8.4. Recent Developments and Strategies
12.9. Promethera Biosciences S.A. / N.V.
12.9.1. Company Overview, Business Information, Manufacturing Area
12.9.2. Product Portfolio Analysis
12.9.2.1. Product Details, Specification, Application
12.9.3. Revenue and Gross Margin (2015-2020)
12.9.4. Recent Developments and Strategies
12.10. Merck Group
12.10.1. Company Overview, Business Information, Manufacturing Area
12.10.2. Product Portfolio Analysis
12.10.2.1. Product Details, Specification, Application
12.10.3. Revenue and Gross Margin (2015-2020)
12.10.4. Recent Developments and Strategies
12.11. Takara Bio Group
12.11.1. Company Overview, Business Information, Manufacturing Area
12.11.2. Product Portfolio Analysis
12.11.2.1. Product Details, Specification, Application
12.11.3. Revenue and Gross Margin (2015-2020)
12.11.4. Recent Developments and Strategies
12.12. Company 12
12.12.1. Company Overview, Business Information, Manufacturing Area
12.12.2. Product Portfolio Analysis
12.12.2.1. Product Details, Specification, Application
12.12.3. Revenue and Gross Margin (2015-2020)
12.12.4. Recent Developments and Strategies

Chapter 13. Research Methodology

13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions

Chapter 14. Appendix

14.1. About Us
14.2. Glossary of Terms

Purchase This Premium Research Report @ https://www.precedenceresearch.com/checkout/1118

About Us

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semiconductors, chemicals, automotive, and aerospace & defence, among different ventures, present globally.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://precedenceresearchnews.wordpress.com

Follow us on LinkedIn | Twitter | Facebook

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

View all posts by Precedence Research →